Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mismatch repair hierarchy of Pseudomonas putida revealed by mutagenic ssDNA recombineering of the pyrF gene

  • Aparicio, Tomás
  • Nyerges, Akos
  • Nagy, Istvan
  • Pal, Csaba
  • Martínez García, Esteban
  • Lorenzo, Víctor de
The mismatch repair (MMR) system is one of the key molecular devices that prokaryotic cells have for ensuring fidelity of DNA replication. While the canonical MMR of E. coli involves 3 proteins (encoded by mutS, mutL and mutH), the soil bacterium Pseudomonads putida has only 2 bona fide homologues (mutS and mutL) and the sensitivity of this abridged system to different types of mismatches is unknown. In this background, sensitivity to MMR of this bacterium was inspected through single stranded (ss) DNA recombineering of the pyrF gene (the prokaryotic equivalent to yeast's URA3) with mutagenic oligos representative of every possible mispairing under either wild‐type conditions, permanent deletion of mutS or transient loss of mutL activity (brought about by the thermoinducible dominant negative allele mutLE36K). Analysis of single nucleotide mutations borne by clones resistant to fluoroorotic acid (5FOA, the target of wild type PyrF) pinpointed prohibited and tolerated single‐nucleotide replacements and exposed a clear grading of mismatch recognition. The resulting data unequivocally established the hierarchy A:G < C:C < G:A < C:A, A:A, G:G, T:T, T:G, A:C, C:T < G:T, T:C as the one prevalent in Pseudomonas putida. This information is vital for enabling recombineering strategies aimed at single‐nucleotide changes in this biotechnologically important species., This work was funded by the HELIOS Project of the SpanishMinistry of Science BIO 2015-66960-C3-2-R (MINECO/FEDER); MADONNA (H2020-FET-OPEN-RIA-2017-1 -766975),BioRoboost (H2020-NMBP-BIO-CSA -2018), and SYN-BIO4FLAV (H2020-NMBP/0500) Contracts of the EuropeanUnion and the S2017/BMD-3691 InGEMICS-CM funded by theComunidad de Madrid (European Structural and InvestmentFunds). CS was supported by grants from the EuropeanResearch Council H2020-ERC-2014-CoG 648364, the Wellcome Trust, GINOP-2.3.2-15-2016-00020, GINOP-2.3.2-15-201 6- 0001 4 and the Lendület Program of th e Hun-garian Academy of Sciences.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multiple-Site Diversification of Regulatory Sequences Enables Interspecies Operability of Genetic Devices

  • Hueso-Gil, Angeles
  • Nyerges, Akos
  • Pal, Csaba
  • Calles, Belén
  • Lorenzo, Víctor de
The features of the light-responsive cyanobacterial CcaSR regulatory module that determine interoperability of this optogenetic device between Escherichia coli and Pseudomonas putida have been examined. For this, all structural parts (i.e., ho1 and pcyA genes for synthesis of phycocyanobilin, the ccaS/ccaR system from Synechocystis, and its cognate downstream promoter) were maintained but their expression levels and stoichiometry diversified by (i) reassembling them together in a single broad host range, standardized vector and (ii) subjecting the noncoding regulatory sequences to multiple cycles of directed evolution with random genomic mutations (DIvERGE), a recombineering method that intensifies mutation rates within discrete DNA segments. Once passed to P. putida, various clones displayed a wide dynamic range, insignificant leakiness, and excellent capacity in response to green light. Inspection of the evolutionary intermediates pinpointed translational control as the main bottleneck for interoperability and suggested a general approach for easing the exchange of genetic cargoes between different species, i.e., optimization of relative expression levels and upturning of subcomplex stoichiometry., This work was funded SETH Project of the Spanish Ministry of Science RTI 2018-095584-B-C42, MADONNA (H2020-FET-OPEN-RIA-2017-1-766975), BioRoboost (H2020-NMBP-BIO-CSA-2018), and SYNBIO4FLAV (H2020-NMBP/0500) Contracts of the European Union and the S2017/BMD-3691 InGEMICS-CM of the Comunidad de Madrid (European Structural and Investment Funds). Sequencing services were provided by the Norwegian Sequencing Centre (Research Council of Norway and the Southeastern Regional Health Authorities). CP was supported by contracts H2020-ERC-2014-CoG 648364, the Wellcome Trust, GINOP MolMedEx TUMORDNS, GINOP-2.3.2-15- 2016-00020, GINOP (EVOMER) GINOP 2.3.2-15-2016- 00014, and the Lendület Program of the Hungarian Academy of Sciences. AN was the recipient of a a PhD fellowship from the Boehringer Ingelheim Fonds. AHG was the recipient of a PhD Fellowship from La Caixa.